Enterprise Value
12.07M
Cash
2.655M
Avg Qtr Burn
-1.749M
Short % of Float
0.00%
Insider Ownership
2.49%
Institutional Own.
2.63%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Bucillamine Details COVID-19 | Phase 3 Update |